Gilead Sciences Inc.’s COVID-19 drug remdesivir will cost much less than Wall Street analysts had predicted in a move that likely points to a more measured and responsible approach to the price of treatments and vaccines during the pandemic. Gilead GILD Shares, It gained 0.9% in trading on Monday following …
Read More »
Shares of Inovio Pharmaceuticals Inc. rebounded to a 20-year high in high volumes on Friday, erasing a previous sharp loss, after a longtime bull downgraded the Pennsylvania-based biotech company, and later that the company disclosed some terms of the funding agreement with the US Department of Defense announced earlier this …
Read More »
Inovio Pharmaceuticals Inc., which has not yet shared the results of the phase 1 trial for its COVID-19 vaccine candidate, has already received millions of dollars in funding to expand manufacturing capacity. An announcement Tuesday that the Defense Department would pay $ 71 million to finance the manufacture of a …
Read More »
Text size Bristol-Myers Squibb is telling analysts this week that its portfolio of developing drugs could generate more sales than anyone expected. In a series of online meetings that started Monday, the drug maker raised its forecast for annual sales it could get from advanced-stage candidates from $ 15 billion …
Read More »